Larcombe, Daniel EBohovych, Iryna MPradhan, ArnabMa, QinxiHickey, EmerLeaves, IanCameron, GaryAvelar, Gabriela Mde Assis, Leandro JChilders, Delma SBain, Judith MLagree, KatherineMitchell, Aaron PNetea, Mihai GErwig, Lars PGow, Neil A RBrown, Alistair J P2023-08-072023-08-072023-07-10Larcombe, D E, Bohovych, I M, Pradhan, A, Ma, Q, Hickey, E, Leaves, I, Cameron, G, Avelar, G M, de Assis, L J, Childers, D S, Bain, J M, Lagree, K, Mitchell, A P, Netea, M G, Erwig, L P, Gow, N A R & Brown, A J P 2023, 'Glucose-enhanced oxidative stress resistance-A protective anticipatory response that enhances the fitness of Candida albicans during systemic infection', PLoS Pathogens, vol. 19, no. 7, pp. e1011505. https://doi.org/10.1371/journal.ppat.10115051553-7366PubMedCentral: PMC10358912ORCID: /0000-0003-2869-7332/work/140032230ORCID: /0000-0002-3977-6733/work/159078589https://hdl.handle.net/2164/21421Acknowledgments We thank Carol Munro for her generosity in providing the plasmids for barcoding C. albicans, and Victoria Brown, Gerry Fink, Bill Fonzi, Guanghua Huang, Joachim Morschauser, Suzanne Noble, Jesus Pla, Patrick Van Dijck, Reinhard Würzner and Oscar Zaragoza for providing strains. We thank our colleagues in the MRC Centre for Medical Mycology and the Aberdeen Fungal Group for insightful discussions. We are grateful to the following Research Facilities for their advice and support: the Centre for Genome Enabled Biology at the University of Aberdeen, and the Sequencing Facility at the University of Exeter for help with the barcode sequencing. Funding: This work was funded by a programme grant to AJPB, NARG, LEP and MGN from the UK Medical Research Council [www.mrc.ac.uk: MR/M026663/1, MR/M026663/2] and by PhD studentships to DEL from the Universities of Aberdeen and Exeter. The work was also supported by the Medical Research Council Centre for Medical Mycology (MR/N006364/1, MR/N006364/2). NARG acknowledges Wellcome support of Senior Investigator (101873/Z/13/Z, 224323/Z/21/Z) and Collaborative (200208/A/15/Z, 215599/Z/19/Z) Awards. MGN was supported by an ERC Advanced Grant (833247) and a Spinoza Grant of the Netherlands Organization for Scientific Research. The barcode sequencing performed by the Exeter Sequencing Facility utilised equipment funded by Wellcome (218247/Z/19/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.2810809engR MedicineMedical Research Council (MRC)MR/M026663/1MR/M026663/2MR/N006364/1MR/N006364/2)Wellcome Trust101873/Z/13/Z224323/Z/21/Z218247/Z/19/ZSupplementary InformationRJournal article10.1371/journal.ppat.1011505197